Self-biting induced by activation of L-type calcium channels in mice: Dopaminergic influences

Developmental Neuroscience

Volumn 25, Issue 1, 2003, Pages 20-25

  Kasim, Suhail ^a   Jinnah, H A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Amphetamine; Dopamine; GBR 12909; Reserpine; Self injurious behavior; Tetrabenazine

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AMPHETAMINE; CALCIUM CHANNEL L TYPE; DOPAMINE; RESERPINE; TETRABENAZINE; VANOXERINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMUTILATION; BITE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; DRUG EFFECT; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; AMPHETAMINE; ANIMALS; BITES, HUMAN; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS, L-TYPE; DOPAMINE; DOPAMINE AGENTS; DOPAMINE UPTAKE INHIBITORS; DRUG SYNERGISM; FEMALE; MALE; MICE; MICE, INBRED C57BL; PIPERAZINES; SELF MUTILATION;

EID: 0041663902     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071464     Document Type: Article

References (47)

1. Berridge MJ: Neuronal calcium signalling. Neuron 1998;21:13-26.
2. 2+ channels. Annu Rev Cell Dev Biol 2000;16:521-555.
3. Bianchi M, Rovati LC, Sacerdote P, Mantegassa P, Panerai AE: Effect of drugs belonging to different classes of calcium channel blockers on experimental seizures induced by the calcium channel agonist Bay K 8644. Neurosci Res Commun 1990;6:157-162.
4. Bolger GT, Weissman BA, Skolnick P: The behavioral effects of the calcium agonist BAY K 8644 in the mouse: Antagonism by the calcium antagonist nifedipine. Naunyn Schmiedebergs Arch Pharmacol 1985;328:373-377.
5. Bourson A, Gower AJ, Mir AK, Moser PC: The effects of dihydropyridine compounds in behavioural tests of dopaminergic activity. Br J Pharmacol 1989;98:1312-1318.
6. Bourson A, Moser PC, Gower AJ, Mir AK: Central and peripheral effects of the dihydropyridine calcium channel activator BAY K 8644 in the rat. Eur J Pharmacol 1989;160:339-347.
7. Jinnah HA, Yitta S, Drew T, Kim BS, Visser JE, Rothstein JD: Calcium channel activation and self-biting in mice. Proc Natl Acad Sci USA 1999;96:15228-15232.
8. Jinnah HA, Sepkuty JP, Ho T, Yitta S, Drew T, Rothstein JD, Hess EJ: Calcium channel agonists and dystonia in the mouse. Mov Disord 2000;15:542-551.
9. O'Neill SK, McKay DW, Campbell N, Triggle CR, Crowley M, Bolger GT: Comparative behavioral, neurochemical, and pharmacological activities of dihydropyridine calcium channel activating drugs. J Pharmacol Exp Ther 1990;253:905-910.
10. Peterson RN: Bay K 8644 induces a reversible spasticity-like syndrome in rats. Eur J Pharmacol 1986;130:323-326.
11. Shelton RC, Grebb JA, Freed WJ: Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY K 8644. Brain Res 1987;402:399-402.
12. Kasim S, Egami K, Jinnah HA: Self-biting induced by activation of L-type calcium channels in mice: Serotonergic influences. Dev Neurosci 2002;24:322-327.
13. Jinnah HA, Gage FH, Friedmann T: Animal models of Lesch-Nyhan syndrome. Brain Res Bull 1990;25:467-475.
14. Visser JE, Baer PR, Jinnah HA: Lesch-Nyhan syndrome and the basal ganglia. Brain Res Rev 2000;32:449-475.
15. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Hardy K, Hankerson JG, Doudet DJ, Cohen RM: Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med 1996;334:1568-1572.
16. Lloyd KG, Hornykiewicz O, Davidson L, Shannak K, Farley I, Goldstein M, Shibuya M, Kelley WN, Fox IH: Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med 1981;305:1106-1111.
17. Saito Y, Ito M, Hanaoka S, Ohama E, Akaboshi S, Takashima S: Dopamine receptor upregulation in Lesch-Nyhan syndrome: A postmortem study. Neuropediatrics 1999;30:66-71.
18. Wong DF, Harris JC, Naidu S, Yokoi F, Marenco S, Dannals RF, Ravert HT, Yaster M, Evans A, Rousset O, Bryan RN, Gjedde A, Kuhar MJ, Breese GR: Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci USA 1996;93:5539-5543.
19. Cromwell HC, Levine MS, King BS: Cortical damage enhances pemoline-induced self-injurious behavior in prepubertal rats. Pharmacol Biochem Behav 1999;62:223-227.
20. Mueller K, Saboda S, Palmour R, Nyhan WL: Self-injurious behavior produced in rats by daily caffeine and continuous amphetamine. Pharmacol Biochem Behav 1982;17:613-617.
21. Mueller K, Nyhan WL: Pharmacologic control of pemoline induced self-injurious behavior in rats. Pharmacol Biochem Behav 1982;16:957-963.
22. Lara-Lemus A, Mora MP, Mendez-Franco J, Palomero-Rivero M, Drucker-Colin R: Effects of REM sleep deprivation on the d-amphetamine-induced self-mutilating behavior. Brain Res 1997;770:60-64.
23. Shishido T, Watanabe Y, Kato K, Horikoshi R, Niwa SI: Effects of dopamine, NMDA, opiate, and serotonin-related agents on acute methamphetamine-induced self-injurious behavior in mice. Pharmacol Biochem Behav 2000;66:579-583.
24. Turner C, Panksepp J, Bekkedal M, Borkowski C, Burgdorf J: Paradoxical effects of serotonin and opioids in pemoline-induced self-injurious behavior. Pharmacol Biochem Behav 1999;63:361-366.
25. Sivam SP: GBR-12909-induced self-injurious behavior: Role of dopamine. Brain Res 1995;690:259-263.
26. Joyce JN, Frohna PA, Neal-Beliveau BS: Functional and molecular differentiation of the dopamine system induced by neonatal denervation. Neurosci Biobehav Rev 1996;20:453-486.
27. Moy SS, Criswell HE, Breese GR: Differential effects of bilateral dopamine depletion in neonatal and adult rats. Neurosci Biobehav Rev 1997;21:425-435.
28. Delfs JM, Kelley AE: The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience 1990;39:59-67.
29. Dickson PR, Lang CG, Hinton SC, Kelley AE: Oral stereotypy induced by amphetamine microinjection into striatum: An anatomical mapping study. Neuroscience 1994;61:81-91.
30. King BH, Au D, Poland RE: Pretreatment with MK-801 inhibits pemoline-induced self-biting behavior in prepubertal rats. Dev Neurosci 1995;17:47-52.
31. Fray PJ, Sahakian BJ, Robbins TW, Koob GF, Iversen SD: An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-amphetamine and apomorphine. Psychopharmacology 1980;69:253-259.
32. Sahgal A: Behavioral Neuroscience: A Practical Approach. New York, Oxford University Press, 1993.
33. Kasim S, Jinnah HA: Thresholds for self-injurious behavior in a genetic mouse model of Lesch-Nyhan disease. Pharmacol Biochem Behav 2002;73:583-592.
34. Woodward JJ, Cook ME, Leslie SW: Characterization of dihydropyridine-sensitive calcium channels in rat brain synaptosomes. Proc Natl Acad Sci USA 1988;85:7389-7393.
35. Woodward JJ, Leslie SW: Bay K 8644 stimulation of calcium entry and endogenous dopamine release in rat striatal synaptosomes antagonized by nimodipine. Brain Res 1986;370:397-400.
36. Nordstrom O, Braisch-Andersen S, Bartfai T: Dopamine release is enhanced while acetylcholine release is inhibited by nimodipine (Bay E 9736). Acta Physiol Scand 1986;126:115-119.
37. 2+ channel antagonists on excitatory amino acid-evoked dopamine release. Eur J Pharmacol 1992;220:203-209.
38. ++ agonist Bay K 8644 increases catecholamine synthesis in mouse brain. Neuropharmacology 1987;26:101-105.
39. Bolger GT, Lesieur P, Basile AS, Skolnick P: Modulation of neurotransmitter metabolism by dihydropyridine calcium channel ligands in mouse brain. Brain Res 1988;438:101-107.
40. 2+ channel in the brain. Life Sci 1998;62:1671-1675.
41. 2+ channels on excessive dopamine release from rat caudate putamen. Physiol Behav 2000;68:641-649.
42. Moore NA, Rees G, Sanger G, Awere S: Effect of L-type calcium channel modulators on stimulant-induced hyperactivity. Neuropharmacology 1993;32:719-720.
43. Surmeier DJ, Bargas J, Hemmings HC, Nairn AC, Greengard P: Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 1995;14:385-397.
44. 2+ conductance. J Neurosci 1997;17:3334-3342.
45. 2+ conductance. Neuroreport 1997;8:2183-2187.
46. 3-calcineurin-signaling cascade. J Neurosci 2000;20:8987-8995.
47. Kabbani N, Negyessy L, Lin R, Goldman-Rakic P, Levenson R: Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci 2002;22:8476-8486.